Gallbladder and bile duct
The gallbladder holds bile, a yellow-green fluid produced in your liver. Bile flows from your liver into your gallbladder. It's held in the gallbladder until needed to help digest food. When you eat, your gallbladder releases bile into the bile duct. The duct carries the bile to the upper part of the small intestine (duodenum) to help break down fat in food.
Cholangiocarcinoma is a type of cancer that forms in the slender tubes (bile ducts) that carry the digestive fluid bile. Bile ducts connect your liver to your gallbladder and to your small intestine.
Cholangiocarcinoma, also known as bile duct cancer, occurs mostly in people older than age 50, though it can occur at any age.
Doctors divide cholangiocarcinoma into different types based on where the cancer occurs in the bile ducts:
- Intrahepatic cholangiocarcinoma occurs in the parts of the bile ducts within the liver and is sometimes classified as a type of liver cancer.
- Hilar cholangiocarcinoma occurs in the bile ducts just outside of the liver. This type is also called perihilar cholangiocarcinoma.
- Distal cholangiocarcinoma occurs in the portion of the bile duct nearest the small intestine. This type is also called extrahepatic cholangiocarcinoma.
Cholangiocarcinoma is often diagnosed when it's advanced, making successful treatment difficult to achieve.
Products & Services
Signs and symptoms of cholangiocarcinoma include:
- Yellowing of your skin and the whites of your eyes (jaundice)
- Intensely itchy skin
- White-colored stools
- Abdominal pain on the right side, just below the ribs
- Losing weight without trying
- Night sweats
- Dark urine
When to see a doctor
See your doctor if you have persistent fatigue, abdominal pain, jaundice, or other signs and symptoms that bother you. He or she may refer you to a specialist in digestive diseases (gastroenterologist).
Get Mayo Clinic cancer expertise delivered to your inbox.
Subscribe for free and receive an in-depth guide to coping
with cancer, plus helpful information on how to get a second opinion. You can unsubscribe at any
ErrorEmail field is required
ErrorInclude a valid email address
To provide you with the most relevant and helpful information, and understand which
information is beneficial, we may combine your email and website usage information with
other information we have about you. If you are a Mayo Clinic patient, this could
include protected health information. If we combine this information with your protected
health information, we will treat all of that information as protected health
information and will only use or disclose that information as set forth in our notice of
privacy practices. You may opt-out of email communications at any time by clicking on
the unsubscribe link in the e-mail.
Thank you for subscribing
Your in-depth coping with cancer guide will be in your inbox shortly. You will also
receive emails from Mayo Clinic on the latest about cancer news, research, and care.
If you don’t receive our email within 5 minutes, check your SPAM folder, then contact us
Sorry something went wrong with your subscription
Please, try again in a couple of minutes
Cholangiocarcinoma happens when cells in the bile ducts develop changes in their DNA. A cell's DNA contains the instructions that tell a cell what to do. The changes tell the cells to multiply out of control and form a mass of cells (tumor) that can invade and destroy healthy body tissue. It's not clear what causes the changes that lead to cholangiocarcinoma.
Factors that may increase your risk of cholangiocarcinoma include:
- Primary sclerosing cholangitis. This disease causes hardening and scarring of the bile ducts.
- Chronic liver disease. Scarring of the liver caused by a history of chronic liver disease increases the risk of cholangiocarcinoma.
- Bile duct problems present at birth. People born with a choledochal cyst, which causes dilated and irregular bile ducts, have an increased risk of cholangiocarcinoma.
- A liver parasite. In areas of Southeast Asia, cholangiocarcinoma is associated with liver fluke infection, which can occur from eating raw or undercooked fish.
- Older age. Cholangiocarcinoma occurs most often in adults over age 50.
- Smoking. Smoking is associated with an increased risk of cholangiocarcinoma.
- Diabetes. People who have type 1 or 2 diabetes may have an increased risk of cholangiocarcinoma.
- Certain inherited conditions. Some DNA changes passed from parents to children cause conditions that increase the risk of cholangiocarcinoma. Examples of these conditions include cystic fibrosis and Lynch syndrome.
To reduce your risk of cholangiocarcinoma, you can:
- Stop smoking. Smoking is linked to an increased risk of cholangiocarcinoma. If you smoke, stop. If you have tried quitting in the past and haven't been successful, talk with your doctor about strategies to help you quit.
Reduce your risk of liver disease. Chronic liver disease is associated with an increased risk of cholangiocarcinoma. Some causes of liver disease can't be prevented, but others can. Do what you can to take care of your liver.
For instance, to reduce your risk of liver inflammation (cirrhosis), drink alcohol in moderation, if you choose to drink. For healthy adults, that means up to one drink a day for women and up to two drinks a day for men. Maintain a healthy weight. When working with chemicals, follow the safety instructions.
Cholangiocarcinoma (bile duct cancer) care at Mayo Clinic
Sept. 02, 2021
- AskMayoExpert. Cholangiocarcinoma (adult). Mayo Clinic; 2020.
- Feldman M, et al., eds. Tumors of the bile ducts, gallbladder and ampulla. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 11th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed Jan. 14, 2021.
- Bile duct cancer (cholangiocarcinoma). Cancer.Net. https://www.cancer.net/cancer-types/bile-duct-cancer/view-all. Accessed April 6, 2021.
- Hepatobiliary cancers. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1438. Accessed Jan. 14, 2021.
- Choi J, et al. Aspirin use and the risk of cholangiocarcinoma. Hepatology. 2016; doi:10.1002/hep.28529.
- Banales JM, et al. Cholangiocarcinoma 2020: The next horizon in mechanisms and management. Nature Reviews Gastroenterology & Hepatology. 2020; doi:10.1038/s41575-020-0310-z.
- Bile duct cancer (cholangiocarcinoma) treatment — Health professional version (PDQ). National Cancer Institute. https://www.cancer.gov/types/liver/hp/bile-duct-treatment-pdq. Accessed April 6, 2021.
- Lowe RC, et al. Clinical manifestations and diagnosis of cholangiocarcinoma. https://www.uptodate.com/contents/search. Accessed April 6, 2021.
- Anderson CD. Surgical resection of localized cholangiocarcinoma. https://www.uptodate.com/contents/search. Accessed April 6, 2021.
- Bergquist JR, et al. Implications of CA-19 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis. Journal of Surgical Oncology. 2016; doi:10.1002/jso.24381.
- Lavu S, et al. Effect of statins on the risk of extrahepatic cholangiocarcinoma. 2020; doi:10.1002/hep.31146.
- Rea DJ, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for Hilar cholangiocarcinoma. 2005; doi:10.1097/01.sla.0000179678.13285.fa.
- Giridhar KV (expert opinion). Mayo Clinic. May 4, 2021.
- Petrick JL, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United State: A population-based study in SEER-Medicare. PLoS ONE. 2017; doi:10.1371/journal.pone.0186643.
- Yamada A, et al. Risk of gastrointestinal cancers in patients with cystic fibrosis: A systematic review and meta-analysis. Lancet Oncology. 2018; doi:10.1016/S1470-2045(18)30188-8.
- Genetic/familial high-risk assessment: Colorectal. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=2&id=1436. Accessed May 28, 2021.
Products & Services
Cholangiocarcinoma (bile duct cancer)